In one of the first studies of its kind, researchers from Wake Forest University School of Medicine explored why blacks are less likely than other races to become living kidney donors, and the reasons are obesity and failure to complete the donor evaluation.
Virginia Bioinformatics Institute and Virginia Tech biological sciences associate professor Chris Lawrence is teaming up with Mayo Clinic on a $2.4 million project funded by the National Institute of Allergy and Infectious Diseases (NIAID). The work could help researchers develop treatments, diagnostic tools, and preventative measures for patients suffering from chronic rhinosinusitis (CRS).
The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.
Unlike many traditional alcohol and drug dependence treatment programs, mainstream smoking cessation programs generally exclude spiritual practice and beliefs from the treatment process. But a study by Oregon Health & Science University Smoking Cessation Center researchers reveals many smokers are receptive to and may benefit from their own spiritual resources, when attempting to quit.
Teenagers who watch television for three or more hours per day may have a higher risk of attention and learning difficulties in their adolescent and early adult years, according to a report in the May issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
A written constitution for the NHS, overseen by an independent Board of Governors are two of the major recommendations published today by the British Medical Association (BMA) in its proposals for the future of the NHS in England.
Bayer plans to enter the market for wound-healing products. Bayer Innovation GmbH ? a subsidiary of Bayer AG ? has developed a leading-edge technology for the manufacture of bioresorbable wound dressings on the basis of silica gel fibers. A ceremony was held on May 4 in Leverkusen to mark the inauguration of a pilot plant which will manufacture the wound dressing in sufficient quantities to enable clinical trials to be carried out.
Bristol-Myers Squibb and the Hepatitis B Foundation announced the launch of the fourth annual “AIM for the B: Awareness, Involvement and Mobilization for Chronic Hepatitis B” program, a public education initiative taking place during National Hepatitis B Awareness Week (May 7-11).
Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), announced that the Company has received two U.S. Food and Drug Administration (FDA) approvals related to its ENJUVIA(TM) (synthetic conjugated estrogens, B) product.
A simple blood test ? beyond standard lab tests ? taken at hospital admission strongly predicted in-hospital mortality risk for heart failure patients and may be useful in helping doctors decide which patients need higher-level monitoring and more intensive treatment.